Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPuma Alpha Vct. Regulatory News (PUAL)

Share Price Information for Puma Alpha Vct. (PUAL)

Share Price is delayed by 15 minutes
Get Live Data
90.50    0.00 (0.00%)
Bid:
83.00
Ask:
98.00
Spread: 15.00 (18.072%)
Market Cap: £32.70m
PUAL Live PriceLast checked at - London Stock Exchange

Intraday Puma Alpha Vct. Share Chart

Issue of Equity

24 Apr 2025 13:38

RNS Number : 0957G
Puma Alpha VCT PLC
24 April 2025
 

 

Puma Alpha VCT plc

 

24 April 2025

 

Issue of Equity

 

The Directors of Puma Alpha VCT plc (the "Company") are pleased to announce that further to an offer for subscription (the "Offer") of ordinary shares of £0.01 each in the Company ("Ordinary Shares") to raise up to £15,000,000, together with an over-allotment facility for up to a further £5,000,000, as set out in a prospectus dated 15 January 2025 (the "Prospectus"), the Company has today made a further allotment of 226,075 Ordinary Shares pursuant to the Offer.

 

In accordance with the allotment formula set out in the Prospectus, the offer prices at which the Ordinary Shares were allotted were in the range of £0.9920 to £1.0123 per Ordinary Share, calculated by reference to the most recently announced net asset value per Ordinary Share (being 99.20p (unaudited) as at 31 March 2025, as announced on 17 April 2025).

 

Following this allotment, the total number of Ordinary Shares in issue is 32,908,086. Therefore, the total number of voting rights in the Company is 32,908,086. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Application will be made for the Ordinary Shares so allotted to be admitted to the Official List of the FCA and to trading on the London Stock Exchange's main market for listed securities, and dealings are expected to commence on or around 28 April 2025. Definitive documents of title are expected to be despatched within 10 business days of allotment.

 

For further information please contact:

 

Eliot Kaye

Company Secretary

Puma Alpha VCT plc

020 7408 4050

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOESEAFELEISEDL
Date   Source Headline
27th Feb 20254:43 pmRNSDirector/PDMR Shareholding
27th Feb 20253:05 pmRNSIssue of Equity
20th Feb 20253:51 pmRNSIssue of Equity
3rd Feb 202510:35 amRNSPortfolio Update
15th Jan 202512:07 pmRNSOffer for Subscription
15th Jan 202511:58 amRNSDividend Declaration
31st Dec 202412:35 pmRNSTotal Voting Rights
18th Dec 20245:26 pmRNSTransaction in Own Shares and Total Voting Rights
4th Dec 202411:53 amRNSIssue of Equity
8th Nov 202411:05 amRNSHalf-year Report
31st Oct 20244:20 pmRNSTotal Voting Rights
24th Oct 20246:10 pmRNSOffer for Subscription – Update
18th Oct 202410:00 amRNSNet Asset Value
2nd Oct 202412:13 pmRNSIssue of Equity
22nd Aug 202412:20 pmRNSIntroduction of a Dividend Reinvestment Scheme
14th Aug 202412:06 pmRNSResult of AGM
1st Aug 202411:23 amRNSTotal Voting Rights
29th Jul 20244:53 pmRNSPortfolio Update
22nd Jul 202411:36 amRNSIssue of Equity
27th Jun 202411:56 amRNSIssue of Second Supplementary Prospectus
25th Jun 20243:43 pmRNSNet Asset Value
14th Jun 20241:38 pmRNSAnnual Financial Report
30th Apr 20244:53 pmRNSTotal Voting Rights
5th Apr 20243:30 pmRNSIssue of Equity
28th Mar 20244:03 pmRNSTotal Voting Rights
19th Mar 20243:26 pmRNSIssue of Equity
12th Mar 20242:04 pmRNSIssue of Supplementary Prospectus
27th Feb 202412:46 pmRNSNet Asset Value(s)
25th Jan 202411:11 amRNSPortfolio Update
4th Jan 202410:59 amRNSPortfolio Update
13th Dec 202312:14 pmRNSOffer for Subscription
5th Dec 202310:21 amRNSIntention to Fundraise
30th Nov 20234:54 pmRNSTotal Voting Rights
10th Nov 202311:41 amRNSHalf-year Report
2nd Nov 20231:56 pmRNSIssue of Equity
19th Oct 20232:26 pmRNSPortfolio Update
17th Oct 202312:33 pmRNSNet Asset Value
28th Sep 20236:06 pmRNSPortfolio Update
27th Sep 20233:07 pmRNSIssue of Equity
12th Sep 20232:57 pmRNSIssue of Equity
31st Aug 20234:15 pmRNSTotal Voting Rights
7th Aug 20233:56 pmRNSIssue of Equity
31st Jul 20235:44 pmRNSTotal Voting Rights
27th Jul 20234:19 pmRNSResult of GM
27th Jul 20234:10 pmRNSResult of AGM
19th Jul 20234:17 pmRNSIssue of Equity
18th Jul 20232:55 pmRNSDividend Declaration
4th Jul 20235:02 pmRNSIssue of Equity
30th Jun 20234:35 pmRNSTotal Voting Rights
28th Jun 20234:47 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.